Claudia Sangalli
YOU?
Author Swipe
View article: Intraductal papilloma of the breast: low risk, but handle with care
Intraductal papilloma of the breast: low risk, but handle with care Open
Surgical resection may be warranted in cases of papillomas with incomplete removal at VABB, where recurrence risk appears to be higher.
View article: Sinonasal Sarcomas Management: An International Consensus Statement
Sinonasal Sarcomas Management: An International Consensus Statement Open
Introduction Sinonasal sarcomas are exceedingly rare entities, constituting less than 7% of head and neck sarcomas. Their complex histology needs specialized treatment, which is often based on multimodal approaches including surgery, radia…
View article: Preliminary Evaluation of Radiomics in Contrast-Enhanced Mammography for Prognostic Prediction of Breast Cancer
Preliminary Evaluation of Radiomics in Contrast-Enhanced Mammography for Prognostic Prediction of Breast Cancer Open
Background: Radiomics is changing clinical practice by providing quantitative information from images to improve diagnosis, prognosis, and treatment planning. This study aims to investigate a radiomics model developed from contrast-enhance…
View article: P290: Cryoablation of Breast Cancer: The Challenge of an Innovative Non-Surgical Treatment for Selected Patients
P290: Cryoablation of Breast Cancer: The Challenge of an Innovative Non-Surgical Treatment for Selected Patients Open
View article: P343: Surgical management of positive margins after breast conservative surgery: 5-years monoistitutional records with 5-years follow-up
P343: Surgical management of positive margins after breast conservative surgery: 5-years monoistitutional records with 5-years follow-up Open
View article: P414: Patient adherence to evidence-based and guidelines-consistent bone health monitoring intervention
P414: Patient adherence to evidence-based and guidelines-consistent bone health monitoring intervention Open
View article: Supplementary Table S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Table S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Table 1. NLR changes after neoadjuvant treatments*
View article: Supplementary Figure S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Figure S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Figure 2. Association of IBPI with postoperative serious complications Clavien-Dindo grade 3 or higher.
View article: Supplementary Table S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Table S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Table 2. Prognostic Index of Inflammatory Biomarkers for primary Retroperitoneal Sarcoma (IBPI)
View article: Supplementary Figure S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Figure S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Figure 1. Relationship between the risk of death, expressed as log-relative hazard from multivariable Cox model, and inflammation-related serum biomarkers.
View article: Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study Open
View article: Influence of Breast Density and Menopausal Status on Background Parenchymal Enhancement in Contrast-Enhanced Mammography: Insights from a Retrospective Analysis
Influence of Breast Density and Menopausal Status on Background Parenchymal Enhancement in Contrast-Enhanced Mammography: Insights from a Retrospective Analysis Open
Background: Contrast-enhanced mammography (CEM) has recently gained recognition as an effective alternative to breast magnetic resonance imaging (MRI) for assessing breast lesions, offering both morphological and functional imaging capabil…
View article: Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis
Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis Open
BACKGROUND: We report on a series of consecutive patients with localized radiation-associated angiosarcoma (RAAS) of the breast region (BR) treated at two Italian sarcoma reference centers. MATERIALS AND METHODS: We retrospectively reviewe…
View article: 236P Survival outcomes of patients (pts) with metastatic lobular breast cancer (mLBC) receiving cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and endocrine therapy (ET): A retrospective analysis
236P Survival outcomes of patients (pts) with metastatic lobular breast cancer (mLBC) receiving cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and endocrine therapy (ET): A retrospective analysis Open
First-line treatment of metastatic breast cancer (mBC) consists of the combination of CDK4/6i & ET, regardless of histoype. Most pts enrolled in clinical trials had ductal mBC, with limited data on CDK4/6i in mLBC. This study aims to analy…
View article: <i>CDH1</i> Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
<i>CDH1</i> Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype Open
Importance Pathogenic or likely pathogenic (P/LP) germline CDH1 variants are associated with risk for diffuse gastric cancer and lobular breast cancer (LBC) in the so-called hereditary diffuse gastric cancer (HDGC) syndrome. However, in so…
View article: Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group Open
View article: Hemodialysis and imatinib: Plasma levels, efficacy and tolerability in a patient with metastatic GIST - Case report
Hemodialysis and imatinib: Plasma levels, efficacy and tolerability in a patient with metastatic GIST - Case report Open
In this case, hemodialysis did not affect significantly imatinib plasma levels. The statistically significant difference between pre- and post-dialysis can be explained by the fact that dialysis may likely contribute to a small portion of …
View article: Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study
Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study Open
View article: Breast Digital Tomosynthesis versus Contrast-Enhanced Mammography: Comparison of Diagnostic Application and Radiation Dose in a Screening Setting
Breast Digital Tomosynthesis versus Contrast-Enhanced Mammography: Comparison of Diagnostic Application and Radiation Dose in a Screening Setting Open
This study aims to evaluate the Average Glandular Dose (AGD) and diagnostic performance of CEM versus Digital Mammography (DM) as well as versus DM plus one-view Digital Breast Tomosynthesis (DBT), which were performed in the same patients…
View article: Supplementary Table S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Table S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Table 2. Prognostic Index of Inflammatory Biomarkers for primary Retroperitoneal Sarcoma (IBPI)
View article: Data from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Data from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Purpose:Inflammatory biomarkers and neutrophil-to-lymphocyte ratio (NLR) are associated with prognosis in several tumors. Data on sarcomas are limited, and insufficient on retroperitoneal sarcoma (RPS).Experimental Design:Patients with pri…
View article: Supplementary Figure S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Figure S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Figure 2. Association of IBPI with postoperative serious complications Clavien-Dindo grade 3 or higher.
View article: Data from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Data from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Purpose:Inflammatory biomarkers and neutrophil-to-lymphocyte ratio (NLR) are associated with prognosis in several tumors. Data on sarcomas are limited, and insufficient on retroperitoneal sarcoma (RPS).Experimental Design:Patients with pri…
View article: Supplementary Figure S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Figure S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Figure 2. Association of IBPI with postoperative serious complications Clavien-Dindo grade 3 or higher.
View article: Supplementary Figure S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Figure S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Figure 1. Relationship between the risk of death, expressed as log-relative hazard from multivariable Cox model, and inflammation-related serum biomarkers.
View article: Supplementary Figure S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Figure S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Figure 1. Relationship between the risk of death, expressed as log-relative hazard from multivariable Cox model, and inflammation-related serum biomarkers.
View article: Supplementary Table S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Table S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Table 1. NLR changes after neoadjuvant treatments*
View article: Supplementary Table S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Table S1 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Table 1. NLR changes after neoadjuvant treatments*
View article: Supplementary Table S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Supplementary Table S2 from Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study Open
Supplemental Table 2. Prognostic Index of Inflammatory Biomarkers for primary Retroperitoneal Sarcoma (IBPI)
View article: Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma
Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma Open
Importance Preclinical data about the synergistic activity of radiotherapy (RT) and trabectedin have been reported. The combination of trabectedin and RT in treating myxoid liposarcomas appears worth exploring. Objective To explore the eff…